Estimation of the prognostic role of patients’ adhesion to treatment and Charlson comorbidity index as predictors of chronic heart failure decompensation


DOI: https://dx.doi.org/10.18565/therapy.2024.9.68-78

Pyrikova N.V., Mozgunov N.A., Osipova I.V., Molchanova A.A.

1) Altai State Medical University of the Ministry of Healthcare of Russia, Barnaul; 2) Regional Clinical Hospital of Emergency Medical Care No. 2, Barnaul
Abstract. Chronic heart failure (CHF) is an important medical, economic and social problem. Studying the problem of CHF comorbidity and patients’ adherence to treatment is important for reducing the risk of CHF decompensation and hospitalization.
The aim: to study the role of adherence of patients to treatment and the role of Charlson comorbidity index as predictors of CHF decompensation.
Material and methods. Medical records of 297 patients admitted with decompensated CHF throughout the year (age 73.3 ± 10.4 years, 58.6% females) were analyzed. All the participants were divided into two groups: patients who had re-hospitalizations (n = 190) and patients without re-hospitalizations for decompensated CHF within 12 months before the index event (n = 107).
Results. Patients with moderate level of comorbidity predominated 1.5 times and patients with significant level of comorbidity predominated 1.3 times among patients with repeated hospitalizations due to decompensated CHF, comparatively to the group without repeated hospitalizations. Charlson comorbidity index of 5 points was associated with re-hospitalization due to decompensated CHF within 12 months (sensitivity 66.32%, specificity 69.16%). In the group of patients with re-hospitalizations, 32.1% of patients complied with recommendations for drug therapy, 17.9% – with non-drug methods and self-control. Adherence to non-drug treatment methods and self-control reduces the chances of re-hospitalization with decompensated CHF within 12 months by 6.6% (95% CI: 0.032–0.133), and adherence to drug treatment by 25.5% (95% CI: 0.136–0.480).
Conclusion. Combination of comorbidity and non-adherence to treatment and self-control increases the risk of hospitalization for decompensated CHF. Further study of factors associated with non-adherence to therapy in patients with CHF is necessary, that will allow to optimize approaches to the management of such kind of the patients.

Literature


1. Savarese G., Becher P.M., Lund L.H. et al. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc Res. 2023; 118(17): 3272–87.


https://doi.org/10.1093/cvr/cvac013. PMID: 35150240.


2. Недогода С.В., Лопатин Ю.М., Архипов М.В. с соавт. Фармакоэпидемиологический анализ рутинной практики ведения пациентов с хронической сердечной недостаточностью в Российской Федерации. Часть II. Российский кардиологический журнал. 2022; 27(2): 9–20. (Nedogoda S.V., Lopatin Yu.M., Arkhipov M.V. et al. Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part II. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2022; 27(2): 9–20 (In Russ.)).


https://doi.org/10.15829/1560-4071-2022-4759. EDN: EQEXSM.


3. Kimmoun A., Takagi K., Gall E. et al. METAHF Team. Temporal trends in mortality and readmission after acute heart failure: A systematic review and meta-regression in the past four decades. Eur J Heart Fail. 2021; 23(3): 420–31.


https://doi.org/10.1002/ejhf.2103. PMID: 33443295.


4. Виллевальде С.В., Соловьева А.Е. Декомпенсация сердечной недостаточности с низкой фракцией выброса: преодоление барьеров для улучшения прогноза в «уязвимый» период после выписки. Кардиология. 2021; 61(12): 82–93. (Villevalde S.V., Soloveva A.E. Decompensated heart failure with reduced ejection fraction: overcoming barriers to improve prognosis in the “vulnerable” period after discharge. Kardiologiya = Cardiology. 2021; 61(12): 82–93 (In Russ.)).


https://doi.org/10.18087/cardio.2021.12.n1860. EDN: MUTYWE.


5. Фофанова Т.В., Суботников М.В., Агеев Ф.Т. Приверженность пациентов терапии после коронарного шунтирования: разные грани одной проблемы. Систематический обзор. Кубанский научный медицинский вестник. 2021; 28(4): 100–117. (Fofanova T.V., Subotnikov M.V., Ageev F.Т. Patient adherence after coronary bypass grafting: Different facets of same matter. A systematic review. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Scientific Medical Bulletin. 2021; 28(4): 100–117 (In Russ.)).


https://doi.org/10.25207/1608-6228-2021-28-4-100-117. EDN: LSTTVO.


6. Scalvini S., Bernocchi P., Villa S. et al. Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients. Int J Cardiol. 2021; 330: 106–11.


https://doi.org/10.1016/j.ijcard.2021.02.016. PMID: 33582198.


7. Виноградова Н.Г., Поляков Д.С., Фомин И.В. Риски повторной госпитализации пациентов с ХСН при длительном наблюдении в специализированном центре лечения ХСН и в реальной клинической практике. Кардиология. 2020; 60(3): 59–69. (Vinogradova N.G., Polyakov D.S., Fomin I.V. The risks of re-hospitalization of patients with heart failure with prolonged follow-up in a specialized center for the treatment of heart failure and in real clinical practice. Kardiologiya = Cardiology. 2020; 60(3): 59–69 (In Russ.)).


https://doi.org/10.18087/cardio.2020.3.n1002. EDN: NYKXXP.


8. Kanaoka K., Iwanaga Y., Nakai M. et al. Multifactorial effects of outpatient cardiac rehabilitation in patients with heart failure: A nationwide retrospective cohort study. Eur J Prev Cardiol. 2022; zwac274.


https://doi.org/10.1093/eurjpc/zwac274. PMID: 36378557.


9. World Health Organization. Ageing and health. URL: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health (date of access – 29.10.2024).


10. Веклич А.С., Козиолова Н.А. Особенности острой декомпенсации сердечной недостаточности у пациентов с сахарным диабетом 2 типа при анемии и латентном железодефиците. Южно-Российский журнал терапевтической практики. 2021; 2(4): 33–42. (Veklich A.S., Koziolova N.A. Features of acute decompensation of heart failure in patients with type 2 diabetes mellitus with anemia and latent iron deficiency. Yuzhno-Rossijskiy zhurnal terapevticheskoy praktiki = South Russian Journal of Therapeutic Practice. 2021; 2(4): 33–42 (In Russ.)).


https://doi.org/10.21886/2712-8156-2021-2-4-33-42. EDN: TFDMDB.


11. Charlson M.E., Pompei P., Ales K.L. et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987; 40(5): 373–83.


https://doi.org/10.1016/0021-9681(87)90171-8. PMID: 3558716.


12. Salah H.M., Minhas A.M.K, Khan M.S. et al. Causes of hospitalization in the USA between 2005 and 2018. Eur Heart J Open. 2021; 1(1): oeab001.


https://doi.org/10.1093/ehjopen/oeab001. PMID: 35919090. PMCID: PMC9242058.


13. Anker S.D., Usman M.S., Anker M.S. et al. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension. Eur J Heart Fail. 2023; 25(7): 936–55.


https://doi.org/10.1002/ejhf.2894. PMID: 37461163.


14. Шляхто Е.В., Беленков Ю.Н., Бойцов С.А. с соавт. Результаты промежуточного анализа проспективного наблюдательного многоцентрового регистрового исследования пациентов с хронической сердечной недостаточностью в Российской Федерации ПРИОРИТЕТ-ХСН: исходные характеристики и лечение первых включенных пациентов. Российский кардиологический журнал. 2023; 28(10): 93–103. (Shlyakhto E.V., Belenkov Yu.N., Boitsov S.A. et al. Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation PRIORITET-CHF: Initial characteristics and treatment of the first included patients. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2023; 28(10): 93–103 (In Russ.)).


https://doi.org/10.15829/1560-4071-2023-5593. EDN: AMDHTV.


15. Айрапетян А.А., Лазарева Н.В., Рейтблат О.М. с соавт. Коморбидные состояния у пациентов с хронической сердечной недостаточностью (по данным регистра хронической сердечной недостаточности в Тюменской области). Consilium Medicum. 2023; 25(10): 685–692. (Airapetyan A.A., Lazareva N.V., Reitblat O.M. et al. Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region). Consilium Medicum. 2023; 25(10): 685–692 (In Russ.)).


https://doi.org/10.26442/20751753.2023.10.202384. EDN: OAEPSC.


16. Lawson C.A., Zaccardi F., Squire I. et al. Risk factors for heart failure. 20-year population-based trends by sex, socioeconomic status, and ethnicity. Circ Heart Fail. 2020; 13(2): e006472.


https://doi.org/10.1161/circheartfailure.119.006472. PMID: 32059630.


17. Ларина В.Н., Барт Б.Я., Карпенко Д.Г. с соавт. Полиморбидность и ее связь с неблагоприятным течением хронической сердечной недостаточности у амбулаторных больных в возрасте 60 лет и старше. Кардиология. 2019; 59(S12): 25–36. (Larina V.N., Bart B.Ya., Karpenko D.G. et al. Polymorbidity and its association with the unfavorable course of chronic heart failure in outpatients aged 60 years and older. Kardiologiia = Cardiology. 2019; 59(S12): 25–36 (In Russ.)).


https://doi.org/10.18087/cardio.n431. EDN: CDIVKK.


18. Ларина В.Н., Замятин К.А., Шерегова Е.Н. с соавт. Приверженность лечению как неотъемлемый компонент тактики ведения пациентов с хронической сердечной недостаточностью. Российский кардиологический журнал. 2024; 29(1): 62–70. (Larina V.N., Zamyatin K.A., Sheregova E.N. et al. Adherence to treatment as an integral component of the management of patients with heart failure. Rossijskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2024; 29(1): 62–70 (In Russ.)).


https://doi.org/10.15829/1560-4071-2024-5690. EDN: KRULNV.


19. Pedretti R.F.E, Hansen D., Ambrosetti M. et al. How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: A clinical consensus statement from the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2023; 30(2): 149–66.


https://doi.org/10.1093/eurjpc/zwac204. PMID: 36098041.


20. McDonagh T.A., Metra M., Adamo M. et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–726.


https://doi.org/10.1093/eurheartj/ehab368. PMID: 34447992.


21. Бунова С.С., Жернакова Н.И., Скирденко Ю.П. с соавт. Приверженность лекарственной терапии, модификации образа жизни и медицинскому сопровождению больных сердечно-сосудистыми заболеваниями. Кардиоваскулярная терапия и профилактика. 2020; 19(6): 38–42. (Bunova S.S., Zhernakova N.I., Skirdenko Yu.P. et al. Adherence to therapy, lifestyle modification and medical support of cardiovascular patients. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2020; 19(6): 38–42 (In Russ.)).


https://doi.org/10.15829/1728-8800-2020-2665. EDN: PWFLBA.


22. Ендубаева Г.В., Соловьева А.Е., Медведев А.Э. с соавт. Анализ соответствия ведения госпитализированных пациентов с хронической сердечной недостаточностью критериям качества медицинской помощи: данные регистра Санкт-Петербурга. Российский кардиологический журнал. 2023; 28(S4): 8–16. (Endubaeva G.V., Solovyova A.E., Medvedev A.E. et al. Compliance of the management of hospitalized patients with heart failure with the quality criteria for health care: Data from the St. Petersburg registry. Rossijskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2023; 28(S4): 8–16 (In Russ.)).


https://doi.org/10.15829/1560-4071-2023-5621. EDN: BBAIJN.


23. Оганов Р.Г., Симаненков В.И., Бакулин И.Г. с соавт. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019; 18(1): 5–66. (Oganov R.G., Simanenkov V.I., Bakulin I.G. et al. Comorbid pathology in clinical practice. Algorithms for diagnosis and treatment. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2019; 18(1): 5–66 (In Russ.)).


https://doi.org/10.15829/1728-8800-2019-1-5-66. EDN: YXKKAP.


24. Rabelo-Silva E.R., Saffi M.A.L., Aliti G.B. et al. Precipitating factors of decompensation of heart failure related to treatment adherence: Multicenter study-EMBRACE. Rev Gaucha Enferm. 2018; 39: e20170292.


https://doi.org/10.1590/1983-1447.2018.20170292. PMID: 30365756.


25. Chen X., Kang Y., Dahlstrom U. et al. Impact of adherence to guideline-directed therapy on risk of death in HF patients across an ejection fraction spectrum. ESC Heart Fail. 2023; 10(6): 3656–66.


https://doi.org/10.1002/ehf2.14358. PMID: 37803813. PMCID: PMC10682881.


26. Гусейнова Э.Т., Кутишенко Н.П., Лукина Ю.В. с соавт. Изучение качества медикаментозной терапии и приверженности к ней у больных хронической сердечной недостаточностью (по данным исследования COMPLIANCE). Рациональная фармакотерапия в кардиологии. 2021; 17(5): 738–742. (Guseynova E.T., Kutishenko N.P., Lukina Yu.V. et al. Study of the quality of medical therapy and adherence in patients with chronic heart failure (according to the COMPLIANCE Study). Ratsional’naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2021; 17(5): 738–742 (In Russ.)).


https://doi.org/10.20996/1819-6446-2021-10-10. EDN: OSPTAP.


About the Autors


Natalya V. Pyrikova, MD, Dr. Sci. (Medicine), associate professor, professor of the Department of faculty therapy and occupational diseases, Altai State Medical University of the Ministry of Healthcare of Russia. Address: 656038, Barnaul, 20 Molodezhnaya St.
E-mail: allinatali@mail.ru
ORCID: https://orcid.org/0000-0003-4387-7737
Nikita A. Mozgunov, MD, head of the Admission Department of Regional Clinical Hospital of Emergency Medical Care No. 2. Address: 656038, Barnaul, 73 build. 2 Komsomolsky Avenue.
E-mail: nikita-mn@mail.ru
ORCID: https://orcid.org/0000-0001-7335-377X
Irina V. Osipova, MD, Dr. Sci. (Medicine), professor, head of the Department of faculty therapy and occupational diseases, Altai State Medical University of the Ministry of Healthcare of Russia. Address: 656038, Barnaul, 20 Molodezhnaya St.
E-mail: i.v.osipova@gmail.com
ORCID: https://orcid.org/0000-0002-6845-6173
Anna A. Molchanova, MD, PhD (Medicine), associate professor of the Department of faculty therapy and occupational diseases, Altai State Medical University of the Ministry of Healthcare of Russia. Address: 656038, Barnaul, 20 Molodezhnaya St.
E-mail: anna2009-84@mail.ru
ORCID: https://orcid.org/0000-0001-5074-8373


Similar Articles


Бионика Медиа